Industry slowly wakens to benefits of initiative to speed up authorisation of multinational clinical trials in the EU
This article was originally published in SRA
Executive Summary
UK agency head Kent Woods extols the virtues of the "voluntary harmonisation procedure" and encourages participation. Maureen Kenny reports.